Pathstone Holdings LLC Grows Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Pathstone Holdings LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 153,486 shares of the healthcare conglomerate's stock after purchasing an additional 1,388 shares during the period. Pathstone Holdings LLC's holdings in UnitedHealth Group were worth $89,731,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Lindenwold Advisors INC raised its stake in UnitedHealth Group by 0.4% in the 3rd quarter. Lindenwold Advisors INC now owns 8,907 shares of the healthcare conglomerate's stock valued at $5,208,000 after acquiring an additional 37 shares during the period. Baron Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 32.1% during the 3rd quarter. Baron Wealth Management LLC now owns 1,923 shares of the healthcare conglomerate's stock worth $1,124,000 after buying an additional 467 shares during the period. Meeder Advisory Services Inc. boosted its holdings in shares of UnitedHealth Group by 9.5% during the third quarter. Meeder Advisory Services Inc. now owns 16,424 shares of the healthcare conglomerate's stock worth $9,603,000 after acquiring an additional 1,420 shares during the period. Semus Wealth Partners LLC lifted its holdings in UnitedHealth Group by 4.4% during the 3rd quarter. Semus Wealth Partners LLC now owns 2,302 shares of the healthcare conglomerate's stock worth $1,346,000 after purchasing an additional 98 shares during the last quarter. Finally, Napa Wealth Management bought a new position in UnitedHealth Group during the 3rd quarter worth $2,393,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Down 2.2 %

NYSE UNH traded down $12.72 during trading hours on Tuesday, reaching $576.93. The company's stock had a trading volume of 3,142,427 shares, compared to its average volume of 3,879,812. The firm has a fifty day simple moving average of $582.31 and a 200-day simple moving average of $551.25. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The stock has a market cap of $530.94 billion, a P/E ratio of 37.59, a P/E/G ratio of 1.74 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts' consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analysts' expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business's quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.56 earnings per share. Equities analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.46%. UnitedHealth Group's dividend payout ratio (DPR) is currently 54.72%.

Analyst Ratings Changes

UNH has been the subject of a number of recent research reports. Barclays cut their price objective on shares of UnitedHealth Group from $604.00 to $603.00 and set an "overweight" rating for the company in a report on Tuesday, October 22nd. KeyCorp started coverage on UnitedHealth Group in a research report on Friday, October 11th. They set an "overweight" rating and a $675.00 target price for the company. Royal Bank of Canada dropped their price target on UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating for the company in a research note on Wednesday, October 16th. Cantor Fitzgerald raised their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an "overweight" rating in a report on Wednesday, October 16th. Finally, Morgan Stanley cut their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a report on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.